Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Immunopharmacology|April 21, 2020
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatmentGabriella di Mauro, Cristina Scavone, Concetta Rafaniello, et al.
Frontiers in Pharmacology|March 1, 2019
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical NeedsCristina Scavone, Gabriella di Mauro, Annamaria Mascolo, et al.
Frontiers in Pediatrics|August 8, 2022
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysisMaria Maddalena Marrapodi, Annamaria Mascolo, Gabriella di Mauro, et al.
Expert Opinion on Drug Safety|October 5, 2017
Drugs approved for the treatment of multiple sclerosis: review of their safety profileFabiana Auricchio, Cristina Scavone, Daniela Cimmaruta, et al.
Expert Opinion on Drug Safety|December 19, 2024
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)Raffaella Di Napoli, Nunzia Balzano, Rosanna Ruggiero, et al.
Expert Review of Clinical Pharmacology|October 15, 2019
The European clinical trials regulation (No 536/2014): changes and challengesCristina Scavone, Gabriella di Mauro, Michela Pietropaolo, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism EventsGabriella di Mauro, Annamaria Mascolo, Miriam Longo, et al.
Frontiers in Immunology|October 20, 2022
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax studyAnnamaria Mascolo, Gabriella di Mauro, Federica Fraenza, et al.
Pharmacological Research|July 12, 2017
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reportingAnnamaria Mascolo, Cristina Scavone, Maurizio Sessa, et al.
Pageof 3